BOSTON, MA — February 3, 2026 — BPGbio, Inc., a biology-first, AI-powered biopharmaceutical company, today proudly announces that its President and CEO, Niven R. Narain, Ph.D., has been named a 2026 Laureate for the prestigious Anthony N. Sabga Award for Caribbean Excellence in the Science & Technology category.
Dr. Narain, a Guyanese-American innovator, was selected for his pioneering work in integrating human biology with Bayesian artificial intelligence to accelerate drug discovery and development. Under his leadership, BPGbio has developed the NAi Interrogative Biology® platform, which has generated more than 450 patents and advanced multiple therapies into clinical trials for aggressive cancers and rare diseases.
Significance of the Award
The Anthony N. Sabga Award for Caribbean Excellence is widely considered the most prestigious private recognition program in the Caribbean region. Established in 2005, the awards aim to identify and support visionary individuals whose work has a significant, positive impact on the Caribbean and its people. As the only program of its kind in the region, it provides Laureates with a gold medal, a citation, and a financial grant—equivalent to TT$500,000—to further their research and community initiatives, fostering a legacy of excellence and regional unity.
Watch the official award presentation video for Dr. Narain on YouTube at 7:05:
